Alnylam Pharmaceuticals, Inc. v. Pfizer Inc.
1:23-cv-00578
Overview
Parties
Defendant
Pharmacia & Upjohn Co. LLC Operating Company
Represented By
5 Attorneys ListedConnolly Gallagher LLP
1201 North Market Street, 20th Floor, Wilmington, DE 19801
Connolly Gallagher LLP
1201 N. Market St., 20th Floor
Pfizer Inc. Operating Company
Represented By
5 Attorneys ListedConnolly Gallagher LLP
1201 North Market Street, 20th Floor, Wilmington, DE 19801
Connolly Gallagher LLP
1201 N. Market St., 20th Floor
Plaintiff
Alnylam Pharmaceuticals, Inc. Operating Company
Represented By
9 Attorneys ListedMcDermott Will & Emery LLP
The Brandywine Building, 1000 N. West Street
Counter Claimant
BioNTech Manufacturing GmbH NPE (Individual / Inventor)
Represented By
1 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Counter Defendant
BioNTech SE NPE (Individual / Inventor)
Represented By
1 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 7 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
Alnylam Pharmaceuticals, Inc. v. Moderna, Inc.
Alnylam Pharmaceuticals, Inc. v. Pfizer Inc.
Alnylam Pharmaceuticals, Inc. v. Moderna, Inc.
Patents Involved
There are 4 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US11633479
Biodegradable lipids for the delivery of active agents
|
Filed: 2022-02-14
Issued: 2023-04-25
|
Active (15.2 yrs remaining)
Expires: 2042-02-14
|
|
|
US11633480
Biodegradable lipids for the delivery of active agents
|
Filed: 2022-02-14
Issued: 2023-04-25
|
Active (15.2 yrs remaining)
Expires: 2042-02-14
|
|
|
US11612657
Biodegradable lipids for the delivery of active agents
|
Filed: 2022-02-14
Issued: 2023-03-28
|
Active (15.2 yrs remaining)
Expires: 2042-02-14
|
|
|
US11590229
Biodegradable lipids for the delivery of active agents
|
Filed: 2022-02-14
Issued: 2023-02-28
|
Active (15.2 yrs remaining)
Expires: 2042-02-14
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked.
Procedural Motions & Interlocutory Orders
Total Motions
5
Dispositive
0
Granted
0
Denied
0
Pending / Review
4
Motions by Category
Key Dispositive Motions & Rulings